Want to join the conversation?
Joseph Spak of RBC Capital asks about North America pricing component for major and carryovers in 4Q15. $GM CFO Chuck Stevens said that pricing in North America was flat overall. Chuck also said that the there is not a lot of major pricing that is expected to see in 2016 with all the product launches.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?